Abstract
The World Health Organization has recently updated their dosing schedule recommendations for the human papillomavirus (HPV) vaccine to include a single-dose schedule. We review the biologic plausibility of a single dose, the evidence from clinical trials, post-licensure observational studies, and mathematical modeling for a single-dose schedule. We also discuss the implications of countries switching to a single-dose program from a two or three-dose schedule. Finally, we review the countries that have currently switched to or introduced the vaccine with a single-dose schedule.
Original language | English (US) |
---|---|
Pages (from-to) | S16-S21 |
Journal | Vaccine |
Volume | 42 |
DOIs | |
State | Published - Jul 11 2024 |
Keywords
- Dosing Schedule
- HPV Vaccine
- Immunisation Programmes
ASJC Scopus subject areas
- Molecular Medicine
- General Immunology and Microbiology
- General Veterinary
- Public Health, Environmental and Occupational Health
- Infectious Diseases